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Glycemic control in insulin and non-insulin dependent
diabetic patients with ST elevation predicts time to
presentation.
Jonathan Evans, David Hamilton, Tigran Khachatryan, Daniel Amponsah, Andrew Stewart,
Islam Abudayyeh, Kenneth R. Jutzy, Eric Suh, Anthony Hilliard
INTRODUCTION
Worldwide, the annual number of
people diagnosed with diabetes continues to
increase. Classically, Diabetes Mellitus (DM)
has been associated with silent or atypical initial
symptoms and increased time to presentation in
patients presenting with ST elevation myocardial
infarction (STEMI) compared to non-DM
patients. It is less clear whether the type of
treatment or the adequacy of glycemic control
impacts the time to presentation and type of
symptoms. Therefore, we sought to evaluate the
impact of poor glycemic control on these
outcomes as measured by hemoglobin A1c

MATERIAL AND METHODS
In this retrospective study, we collected
and analyzed data from 766 patients who
presented to a tertiary-care university medical
center with STEMI from 2008-2015. Over that
timeframe, 238 of the 766 (31%) patients who
presented with STEMI had DM. A T-test was
performed comparing mean time to presentation
in diabetics vs. non-diabetics, whereas both ttests and χ2 tests were used to compare
presenting symptoms between the two groups.
Regression analysis was performed comparing
time to presentation to hemoglobin A1c.

RESULTS
Diabetic patients presenting with
STEMI on average presented 50 minutes later
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than non- diabetic patients (194.8 minutes vs.
144.7 minutes, p = 0.0054). Furthermore, time to
presentation increased (p = 0.0035) for every
unit increase in hemoglobin A1c level (p =
0.0035). Chest pain was the most common
presenting symptom in diabetic and non-diabetic
patients with similar rates in both groups (87.4%
v 89.1%, p = 0.561). No statistically significant
difference was found in rates of shortness of
breath, syncope, or GI symptoms between the
two groups.

CONCLUSION
Diabetic patients have delayed time to
presentation compared to non-diabetic patients
with STEMI. Additionally, the worse the
glycemic control the longer the time to
presentation. However, in contrast to prior
observations, both diabetic and non-diabetic
patients presented with similar rates of chest
pain.
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